1 / 8NMDC | State-owned company reported a 62.6% year-on-year jump in net profit at ₹1,469.7 crore for the third quarter that ended December 31, 2023. In the corresponding quarter last year, NMDC posted a net profit of ₹903.9 crore. The company's revenue from operations increased 45.4% to ₹5,409.9 crore against ₹3,720 crore in the corresponding period of the preceding fiscal.
2 / 8Muthoot Finance | Gold loan-focused non-bank lender reported a 13.9% year-on-year increase in net profit at ₹1,027.3 crore for the third quarter that ended December 31, 2023. In the corresponding quarter last year, Muthoot Finance had posted a net profit of ₹901.7 crore. Net interest income (NII) rose 11.8%, coming at ₹1,905.7 crore against ₹1,704 crore in the corresponding quarter of FY23.
3 / 8Sun TV Network | Broadcasting major reported a 6.8% year-on-year increase in net profit at ₹453.9 crore for the third quarter that ended December 31, 2023. In the corresponding quarter last year, Sun Television posted a net profit of ₹425 crore. The company's revenue from operations increased 4.1% to ₹923.2 crore against ₹886.9 crore in the corresponding period of the preceding fiscal.
4 / 8Glenmark Pharma | Drug firm on Wednesday reported a net loss of ₹330.8 crore for the third quarter that ended December 31, 2023. In the corresponding quarter last year, Glenmark posted a net profit of ₹290.7 crore. The company's revenue from operations declined 19.1% to ₹2,506.7 crore as against ₹3,100 crore in the corresponding period of the preceding fiscal.
5 / 8REC | State-run company on Wednesday signed agreements worth ₹588 crore with Damodar Valley Corporation for the development of tubed coal mines in the Damodar Valley region. The agreements aim to strengthen the cooperation between REC and DVC for the development of tubed coal mines and include a term loan agreement, an escrow agreement, and hypothecation deeds.
6 / 8Gland Pharma | Drug firm on Wednesday reported a 17.3% year-on-year decline in net profit at ₹191.9 crore for the third quarter that ended December 31, 2023. In the corresponding quarter last year, Gland Pharma posted a net profit of ₹231.9 crore. The company's revenue from operations jumped 64.7% to ₹1,545.2 crore against ₹938.3 crore in the corresponding period of the preceding fiscal.
7 / 8Crompton Greaves | The company on Wednesday reported a 3.1% decline in its consolidated net profit to ₹85.45 crore for the third quarter ended December 2023. The company had posted a net profit of ₹88.19 crore in the October-December quarter a year ago. However, its revenue from operations rose 11.63% to ₹1,692.69 crore in the quarter under review.
8 / 8PTC India | Power trading solutions provider on Wednesday reported over 7% fall in its consolidated net profit to ₹97.04 crore for the December 2023 quarter. It had clocked a net profit of ₹104.48 crore in the year-ago period. The company's total income, however, increased to ₹3,483.93 crore from ₹3,146.91 crore a year ago.
